Pharmaceutical supply chain models: A synthesis from a systems view of operations research

This research evaluates reconfiguration opportunities in Pharmaceutical Supply Chains (PSC) resulting from technology interventions in manufacturing, and new, more patient-centric delivery models. A critical synthesis of the academic and practice literature is used to identify, conceptualise, analyse and categorise PSC models. From a theoretical perspective, a systems view of operations research is adopted to provide insights on a broader range of OR activities, from conceptual to mathematical modelling and model solving, up to implementation.

[1]  Ana Paula F. D. Barbosa-Póvoa,et al.  The effect of uncertainty on the optimal closed-loop supply chain planning under different partnerships structure , 2009, Comput. Chem. Eng..

[2]  Tan Miller,et al.  Implementing a Distribution-Network Decision-Support System at Pfizer/Warner-Lambert , 2002, Interfaces.

[3]  Alexandros Koulouris,et al.  The Role of Process Simulation in Pharmaceutical Process Development and Product Commercialization , 2002 .

[4]  Adam J. Fleischhacker,et al.  Positioning Inventory in Clinical Trial Supply Chains , 2015 .

[5]  Christos T. Maravelias,et al.  A stochastic programming approach for clinical trial planning in new drug development , 2008, Comput. Chem. Eng..

[6]  Nilay Shah,et al.  Pharmaceutical supply chains: key issues and strategies for optimisation , 2004, Comput. Chem. Eng..

[7]  K. Hannes,et al.  Synthesizing Qualitative Research: Choosing the Right Approach , 2012 .

[8]  Eric Jack,et al.  A Review and Synthesis of Demand Management, Capacity Management and Performance in Health-Care Services , 2009 .

[9]  E. Clemons.  Using Scenario Analysis to Manage the Strategic Risks of Reengineering , 1995 .

[10]  J. Shapiro.  Modeling the Supply Chain , 2000 .

[11]  Marcelo Caldeira Pedroso,et al.  19 th International Conference on Production Research KNOWLEDGE AND INFORMATION FLOWS IN SUPPLY CHAINS: A STUDY ON PHARMACEUTICAL COMPANIES , 2022 .

[12]  Hung-Chang Liao,et al.  The optimal approach for parameter settings based on adjustable contracting capacity for the hospital supply chain logistics system , 2011, Expert Syst. Appl..

[13]  Anca Ioana Nicolau,et al.  Quantitative modelling to estimate the transfer of pharmaceuticals through the food production system , 2014, Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes.

[14]  Marie Schmidt,et al.  HEAL TH AT A GLANCE , 2007 .

[15]  Ignacio E. Grossmann,et al.  Optimization Models for the Scheduling of Testing Tasks in New Product Development , 1996 .

[16]  Jagjit Singh Srai,et al.  Evaluating the potential for the continuous processing of pharmaceutical products - a supply network perspective , 2015 .

[17]  Amir H. Masoumi,et al.  A Supply Chain Generalized Network Oligopoly Model for Pharmaceuticals under Brand Differentiation and Perishability , 2012 .

[18]  Iftekhar A. Karimi,et al.  Supply chain redesign and new process introduction in multipurpose plants , 2010 .

[19]  Lazaros G. Papageorgiou,et al.  An Aggregation Approach for Capacity Planning under Uncertainty for the Pharmaceutical Industry , 2003 .

[20]  Sally Thorne,et al.  Meta-Study of Qualitative Health Research , 2001 .

[21]  I. Grossmann,et al.  Simultaneous Planning for New Product Development and Batch Manufacturing Facilities , 2001 .

[22]  Klaus Reinholdt Nyhuus Hansen,et al.  Planning operations before market launch for balancing time-to-market and risks in pharmaceutical supply chains , 2015 .

[23]  J. Schmitz,et al.  A strategic review of “supply networks” , 2004 .

[24]  Abdul V. Roudsari,et al.  The applicability of a multi‐attribute classification framework in the healthcare industry , 2006 .

[25]  Hing Kai Chan,et al.  The future trend on system-wide modelling in supply chain studies , 2005 .

[26]  Ian I. Mitroff,et al.  Operations research from the viewpoint of general systems theory , 1973 .

[27]  Jürgen Strohhecker,et al.  Integrating Kanban principles in a pharmaceutical campaign production system , 2014 .

[28]  Angel B. Ruiz,et al.  Scheduling logistic activities to improve hospital supply systems , 2007, Comput. Oper. Res..

[29]  Heiko Gebauer,et al.  Robust management policies for positioning pharmacies as healthcare service providers , 2008 .

[30]  Celia Ponder,et al.  Cradle-to-gate life cycle inventory of vancomycin hydrochloride. , 2010, The Science of the total environment.

[31]  Richard T. Watson,et al.  Analyzing the Past to Prepare for the Future: Writing a Literature Review , 2002, MIS Q..

[32]  Yves Dallery,et al.  Exploring new operational research opportunities within the Home Care context: the chemotherapy at home , 2009, Health care management science.

[33]  J. Grossman,et al.  Building a Better Delivery System: A New Engineering/Health Care Partnership , 2005 .

[34]  Manoj Kumar Tiwari,et al.  Application of an analytical network process to strategic planning problems of a supply chain cell: case study of a pharmaceutical firm , 2004 .

[35]  Jeroen Beliën,et al.  Supply chain management of blood products: A literature review , 2012, Eur. J. Oper. Res..

[36]  Stefan Gold,et al.  Supply chain management as Lakatosian research program , 2014 .

[37]  Tuomas J. Lahtinen,et al.  Path dependence in Operational Research—How the modeling process can influence the results , 2016 .

[38]  Sameer Kumar,et al.  Reverse logistic process control measures for the pharmaceutical industry supply chain , 2009 .

[39]  AliReza Madadi,et al.  Supply network design: Risk-averse or risk-neutral? , 2014, Comput. Ind. Eng..

[40]  Sam Debaveye,et al.  Environmental sustainability assessments of pharmaceuticals: an emerging need for simplification in life cycle assessments. , 2014, Environmental science & technology.

[41]  S. Godtfredsen,et al.  Ullmann ' s Encyclopedia of Industrial Chemistry , 2017 .

[42]  Stefan Seuring,et al.  Cost management in supply chains , 2002 .

[43]  D. Tranfield,et al.  Towards a Methodology for Developing Evidence-Informed Management Knowledge by Means of Systematic Review , 2003 .

[44]  Yao Zhao,et al.  Planning for demand failure: A dynamic lot size model for clinical trial supply chains , 2011, Eur. J. Oper. Res..

[45]  Ignacio E. Grossmann,et al.  Optimal resource investment and scheduling of tests for new product development , 2004, Comput. Chem. Eng..

[46]  J. Pekny,et al.  Managing a Portfolio of Interdependent New Product Candidates in the Pharmaceutical Industry , 2004 .

[47]  Ana Paula Barbosa-Póvoa,et al.  Process Supply Chains Management – Where are We? Where to Go Next? , 2014, Front. Energy Res..

[48]  Bo Yang,et al.  4/R/I/T distribution logistics network 0-1 programming model and application , 2008, Comput. Ind. Eng..

[49]  Jagjit Singh Srai,et al.  A supply network configuration perspective on international supply chain development , 2008 .

[50]  Nico Vandaele,et al.  A review of integrated supply chain network design models: Key issues for vaccine supply chains , 2016 .

[51]  Christian L. Rossetti,et al.  Forces, trends, and decisions in pharmaceutical supply chain management , 2011 .

[52]  Natalie Privett,et al.  The top ten global health supply chain issues: Perspectives from the field , 2014 .

[53]  Gintaras V. Reklaitis,et al.  Simulation-optimization approach to clinical trial supply chain management with demand scenario forecast , 2012, Comput. Chem. Eng..

[54]  Jeroen Belien,et al.  Supply chain management of blood products: A literature review , 2012 .

[55]  Luc Pibouleau,et al.  Multiobjective strategies for New Product Development in the pharmaceutical industry , 2012, Comput. Chem. Eng..

[56]  L. Breen,et al.  Who cares wins? A comparative analysis of household waste medicines and batteries reverse logistics systems , 2014 .

[57]  Marcus Brandenburg,et al.  Quantitative models for sustainable supply chain management: Developments and directions , 2014, Eur. J. Oper. Res..

[58]  Daniel Tonke,et al.  Pattern-based supply network planning in the pharmaceutical industry , 2015, Comput. Chem. Eng..

[59]  J. Vorst,et al.  Resource-efficient supply chains: a research framework, literature review and research agenda , 2015 .

[60]  Hanif D. Sherali,et al.  Primary pharmaceutical manufacturing scheduling problem , 2014 .

[61]  Thomas K. Dasaklis,et al.  Epidemics control and logistics operations: A review , 2012 .

[62]  Helmut Schneider,et al.  Pharmaceutical supply chain specifics and inventory solutions for a hospital case , 2012 .

[63]  Paul I. Barton,et al.  Capacity Planning under Clinical Trials Uncertainty in Continuous Pharmaceutical Manufacturing, 1: Mathematical Framework , 2012 .

[64]  Derek L. Waller,et al.  Operations Management: A Supply Chain Approach , 1999 .

[65]  R. Uthayakumar,et al.  Pharmaceutical supply chain and inventory management strategies: Optimization for a pharmaceutical company and a hospital , 2013 .

[66]  Francesco Longo.  Sustainable supply chain design: an application example in local business retail , 2012, Simul..

[67]  Patrick Lydon,et al.  Integration of vaccine supply chains with other health commodity supply chains: a framework for decision making. , 2014, Vaccine.

[68]  Hui Zhao,et al.  Fee-for-Service Contracts in Pharmaceutical Distribution Supply Chains: Design, Analysis, and Management , 2012, Manuf. Serv. Oper. Manag..

[69]  R. K. Pati,et al.  Managerial research on the pharmaceutical supply chain - A critical review and some insights for future directions , 2014 .

[70]  Arun Abraham Elias,et al.  Reverse logistics in the pharmaceuticals industry: a systemic analysis , 2014 .

[71]  Wouter De Soete,et al.  Environmental resource footprinting of drug manufacturing: Effects of scale-up and tablet dosage , 2014 .

[72]  Goutam Dutta,et al.  An optimization-based decision support system for strategic planning in a process industry: The case of a pharmaceutical company in India , 2007 .

[73]  B. Beamon.  Supply chain design and analysis:: Models and methods , 1998 .

[74]  Jagjit Singh Srai,et al.  Reconfiguring global pharmaceutical value networks through targeted technology interventions , 2017, Int. J. Prod. Res..

[75]  Adel Hatami-Marbini,et al.  Frontier-based performance analysis models for supply chain management: State of the art and research directions , 2013, Comput. Ind. Eng..

[76]  Jayashankar M. Swaminathan,et al.  Distributing Scarce Drugs for the Medpin Program , 2004, Interfaces.

[77]  Thomas Y. Choi,et al.  Toward the Theory of the Supply Chain , 2015 .

[78]  Anup Kumar,et al.  Dynamic performance assessment of a supply chain process: A case from pharmaceutical supply chain in India , 2015, Bus. Process. Manag. J..

[79]  Ruth Sara Aguilar-Savén,et al.  Business process modelling: Review and framework , 2004 .

[80]  Anna Nagurney,et al.  Pharmaceutical Supply Chain Networks with Outsourcing Under Price and Quality Competition , 2013, Int. Trans. Oper. Res..

[81]  Qiang Chen,et al.  A Health-IoT Platform Based on the Integration of Intelligent Packaging, Unobtrusive Bio-Sensor, and Intelligent Medicine Box , 2014, IEEE Transactions on Industrial Informatics.

[82]  Brian Wilson,et al.  Soft Systems Methodology: Conceptual Model Building and Its Contribution , 2001 .

[83]  N. Shah,et al.  Strategic Supply Chain Optimization for the Pharmaceutical Industries , 2001 .

[84]  Liz Breen,et al.  Greening community pharmaceutical supply chain in UK: a cross boundary approach , 2012 .

[85]  P. Danese.  The extended VMI for coordinating the whole supply network , 2006 .

[86]  L. Ellram.  Total Cost of Ownership: Elements and Implementation , 1993 .

[87]  Reza Zanjirani Farahani,et al.  A review and critique on integrated production–distribution planning models and techniques , 2013 .

[88]  Roger E. Bohn,et al.  Chapter 17 – Measuring and Managing Technological Knowledge , 1998 .

[89]  J.M. Laínez,et al.  Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry , 2012, Comput. Chem. Eng..

[90]  J. Wacker.  A theory of formal conceptual definitions: developing theory-building measurement instruments , 2004 .

[91]  Ali Rajabzadeh Ghatari,et al.  Developing a model for an agile supply chain in pharmaceutical industry , 2015 .

[92]  Gintaras V. Reklaitis,et al.  Enterprise-wide modeling & optimization - An overview of emerging research challenges and opportunities , 2007, Comput. Chem. Eng..

[93]  Robert Handfield,et al.  A multi-agent simulation of the pharmaceutical supply chain , 2012, J. Simulation.

[94]  Iftekhar A. Karimi,et al.  Integrated supply chain planning for multinational pharmaceutical enterprises , 2011, Comput. Chem. Eng..

[95]  S. Seuring,et al.  Conducting content‐analysis based literature reviews in supply chain management , 2012 .

[96]  Iftekhar A. Karimi,et al.  Planning in Pharmaceutical Supply Chains with Outsourcing and New Product Introductions , 2004 .

[97]  Hirokazu Sugiyama,et al.  Improving lead time of pharmaceutical production processes using Monte Carlo simulation , 2014, Comput. Chem. Eng..

[98]  Sun-Kyoung Shin,et al.  Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. , 2011, Chemosphere.

[99]  Anna Nagurney,et al.  A supply chain network game theory model with product differentiation, outsourcing of production and distribution, and quality and price competition , 2015, Ann. Oper. Res..

[100]  Gintaras V. Reklaitis,et al.  Integrated Planning and Optimization of Clinical Trial Supply Chain System with Risk Pooling , 2012 .

[101]  Gang Yang,et al.  Plant co-ordination in pharmaceutics supply networks , 2003, OR Spectr..

[102]  S. K. Srivastava.  Towards estimating Cost of Quality in supply chains , 2008 .

[103]  Lazaros G. Papageorgiou,et al.  A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry , 2004, Comput. Chem. Eng..

[104]  Krist V. Gernaey,et al.  Process Systems Engineering, 9. Domain Engineering , 2012 .

[105]  J. Bertrand,et al.  Operations management research methodologies using quantitative modeling , 2002 .

[106]  Steven A. Melnyk,et al.  Would you mind completing this survey: Assessing the state of survey research in supply chain management , 2012 .

[107]  Lazaros G. Papageorgiou,et al.  Supply chain optimisation for the process industries: Advances and opportunities , 2009, Comput. Chem. Eng..

[108]  Norm Archer,et al.  Supply Management for Home Healthcare Services , 2008, INFOR Inf. Syst. Oper. Res..

[109]  Lazaros G. Papageorgiou,et al.  Global supply chain planning for pharmaceuticals , 2011 .

[110]  E. Zeydan,et al.  On the Integration of AI/ML-based scaling operations in the 5Growth platform , 2020, 2020 IEEE Conference on Network Function Virtualization and Software Defined Networks (NFV-SDN).

[111]  Henri C. Dekker,et al.  Supply Chain Management and Management Accounting: A Case Study of Activity-Based Costing , 2000 .

[112]  Gintaras V. Reklaitis,et al.  Simulation-optimization framework for stochastic optimization of R&D pipeline management , 2003 .

[113]  J. Rantanen,et al.  The Future of Pharmaceutical Manufacturing Sciences , 2015, Journal of pharmaceutical sciences.

[114]  Sven Stegemann,et al.  The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[115]  Ewart R. Carson,et al.  Dealing with complexity: an introduction to the theory & applications of systemsscience , 1988 .

[116]  Alexander Zeier,et al.  Costs of authentic pharmaceuticals: research on qualitative and quantitative aspects of enabling anti-counterfeiting in RFID-aided supply chains , 2011, Personal and Ubiquitous Computing.

[117]  Rahul C. Basole,et al.  Network analysis of supply chain systems: A systematic review and future research , 2013, Syst. Eng..

[118]  Ana Paula F. D. Barbosa-Póvoa,et al.  Planning and scheduling of industrial supply chains with reverse flows: A real pharmaceutical case study , 2008, Comput. Chem. Eng..

[119]  Reza Tavakkoli-Moghaddam,et al.  A replenishment policy based on joint optimization in a downstream pharmaceutical supply chain: centralized vs. decentralized replenishment , 2011 .